Study number 8530-880
1 stay of 14 nights and 1 call
Dates
Jul 14 2024-Aug 10 2024
Location
Dallas, Texas
Age
18-55
Gender
Both
Smoker
Compensation
$5,860
Group
G3
Study Details
The investigational drug in this research study is being studied for the treatment of inflammatory diseases.
The main purpose of this study is to assess the safety and tolerability of single or multiple doses of the study drug when administered alone or in combination with digoxin, rosuvastatin, or metformin.
Fortrea Dallas, TX is recruiting for:
-Healthy Males and Females, age 18-55
-Body Mass Index between 18-30.5
-Study involves 1 stay of 14 nights & 1 follow-up call
-Compensation up to $5,860 may be provided for time and participation
-Refer a friend to receive $300 per qualified referral
Additional Details
G3:
Check-in: Jul 14
Check-out: Jul 28
Call: Aug 10